Harvoni tv commercials
TV spots
TV commercials Harvoni
Harvoni is a medication that is used to treat hepatitis C. In the Harvoni TV spot titled 'I Am Ready', we see various individuals standing and sitting in front of the camera, each stating their readiness to take on life after undergoing treatment with Harvoni.The advertisement opens with a man stand...
Title: Harvoni TV Spot, 'Let Go'Intro:In the ever-evolving realm of television advertising, there are campaigns that resonate deeply with viewers, leaving a lasting impact on their hearts and minds. One such campaign is the Harvoni TV Spot, entitled 'Let Go.' This captivating commercial invites view...
Agenices
Agencies worked with Harvoni
Horizon Media, Inc.
Horizon Media, Inc. is a leading media agency headquartered in New York City. Founded in 1989 by Bill Koenigsberg, the agency has grown to become one of the largest independent media agencies in the world, with over 2,300 employees across its 19 offices in the United States, Canada, and the United Kingdom.With a client roster that includes major brands such as Geico, Corona, and Weight Watchers, Horizon Media has earned a reputation for its innov...
Actors
Actors who starred in Harvoni commercials
What kind of company is Harvoni?
Harvoni is not a company, but rather a medication. It is a combination drug that is used to treat chronic hepatitis C virus (HCV) infection in adults. Harvoni was developed by the pharmaceutical company Gilead Sciences Inc.
Gilead Sciences Inc. is a biopharmaceutical company based in the United States. It specializes in the development and commercialization of innovative medicines in areas such as liver diseases, HIV/AIDS, viral hepatitis, respiratory diseases, and more. The company's mission is to advance the care of patients suffering from life-threatening diseases around the world.
Harvoni, which contains the active ingredients ledipasvir and sofosbuvir, was approved by the U.S. Food and Drug Administration (FDA) in 2014. It revolutionized the treatment of hepatitis C by providing a highly effective and well-tolerated oral therapy. Harvoni offers a convenient once-daily treatment regimen that can cure hepatitis C infection in a significant number of patients.
The drug works by targeting specific proteins in the hepatitis C virus, inhibiting its replication and leading to a significant reduction in viral load. Depending on the genotype of the hepatitis C virus and other factors, treatment duration with Harvoni can range from 8 to 24 weeks.
It's important to note that Harvoni is a prescription medication and should only be taken under the supervision of a healthcare professional. Before starting treatment, patients should be evaluated for potential contraindications or drug interactions.
The approval of Harvoni marked a significant milestone in the treatment of hepatitis C and has helped improve the lives of millions of patients worldwide. Gilead Sciences Inc. continues to invest in research and development to further advance the field of liver diseases and bring innovative treatments to patients in need.
Please consult with a healthcare professional or refer to the official prescribing information and patient resources for comprehensive and accurate information about Harvoni and its approved indications, usage, and potential side effects.
